Prognosis
FDA Lays Out Annual Covid Shot Plan Similar to Flu
- Health officials to meet at least annually to review strains
- FDA seeks one composition for all manufacturers’ vaccines
Photographer: Waldo Swiegers/Bloomberg
This article is for subscribers only.
Americans will get a clearer idea of how often they’ll roll up their sleeves for Covid-19 shots when advisers to US regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.
The plan would have health officials meet each June to review which strains of the virus should be included in Covid shots to be deployed no later than September of the same year, according to documents released by the US Food and Drug Administration ahead of the Jan. 26 meeting. Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE are the biggest makers of doses for the US.